Executive Summary
Across 20 Sensex 30-related filings from April 27, 2026, key themes include transformative M&A in pharma (Sun Pharma's $11.75B Organon acquisition doubling EBITDA), mixed IT/services performance with modest FY27 guidance (Infosys 1.5-3.5% YoY CC, LTTS 13-15% CAGR target), robust capital allocation via dividends/bonuses (UltraTech 2400% payout, Trent 1:2 bonus), and steady financial growth in cards/banking (SBI Cards FY26 revenue +10.1% YoY, PAT +13%). Period-over-period trends show FY26 revenue acceleration in select names (LTTS +8.3% YoY, SBI Cards +10.1%) but QoQ softness (LTTS Q4 -1.7%, SBI Cards Q4 rev -3.7%), with no insider trading activity reported but positive governance votes (HDFC 98.3% approval). Portfolio-level patterns reveal sector divergence: bullish realty/infra expansions (L&T 3.6M sq ft Gurugram land), neutral fundraising/governance, and mixed sentiment in 7/20 filings driven by growth headwinds vs strategic initiatives. Critical implications: near-term catalysts from earnings calls/board meets could drive volatility, while Sun Pharma deal positions it as top-25 global pharma player by early 2027.
Tracking the trend? Catch up on the prior BSE Sensex 30 Stocks Regulatory Filings digest from April 20, 2026.
Investment Signals(12)
- Sun Pharmaceutical↓(BULLISH)▲
Definitive $11.75B Organon acquisition at $14/share nearly doubles EBITDA/cash flow, top-3 Women's Health positioning, pro forma revenue $12.4B
- Trent Limited↓(BULLISH)▲
1:2 bonus issue record date May 29, 2026, plus dividend record June 10 ahead of June 23 AGM, signaling strong cash position
- UltraTech Cement↓(BULLISH)▲
Recommended 2400% dividend (Rs.240/share) on FY26 audited results with unmodified opinion, despite penalties
- SBI Cards↓(BULLISH)▲
FY26 revenue +10.1% YoY to Rs.19,899 Cr, PAT +13% to Rs.2,166 Cr, loans +2% YoY to Rs.54,984 Cr
- LTTS(BULLISH)▲
FY26 revenue $1,233M +8.3% YoY, Tech segment +19.7%, large deals $855M +40% YoY, Lakshya 31-Plan targets 13-15% CAGR/16-17% EBIT
- L&T↓(BULLISH)▲
Wholly-owned LTRPL acquires 100% IGSL for 20 acres Gurugram land (3.6M sq ft potential), FY26 cumulative acquisitions 3M sq ft across cities
- TCS(BULLISH)▲
MoUs with Siemens Energy for AI-led transformation/IT services, building on 20-year partnership, supports HyperVault AI data centers
- HDFC Bank↓(BULLISH)▲
Postal ballot re-appointment of Independent Director passes 98.322% approval (65% turnout), strong institutional support 98.329%
- Mahindra & Mahindra↓(NEUTRAL-BULLISH)▲
Additional 28.03% stake in Carnot to 80.72% equity/89% voting for Rs.6.72 Cr, aligns precision farming strategy despite Carnot FY26 rev decline
- Infosys↓(MIXED-BEARISH)▲
FY26 revenue +3.1% CC, Q4 +4.1% YoY CC, large deals $14.9B +28% YoY, AI services >5.5% of Q4 revenue, but FY27 guide 1.5-3.5% CC
- Power Grid↓(BULLISH)▲
Board meet Apr 30 for unsecured rupee term loan/credit line fundraising, potential capex boost
- Adani Ports↓(NEUTRAL)▲
IEPFA 'Saksham Niveshak' campaign to July 9 encourages KYC/dividend claims, proactive shareholder protection
Risk Flags(10)
- Infosys/Guidance Cut↓[HIGH RISK]▼
FY27 revenue guidance modest 1.5-3.5% YoY CC vs FY26 3.1%, citing AI productivity, competition, client compression; employee count -8,000 over 5-6 quarters
- LTTS/QoQ Decline[MEDIUM RISK]▼
Q4 FY26 revenue $306M -1.7% QoQ/+0.3% YoY due to portfolio rationalization, Mobility flat sequentially
- SBI Cards/QoQ Revenue Drop↓[MEDIUM RISK]▼
Q4 FY26 revenue -3.7% QoQ to Rs.4,934 Cr despite +5.6% YoY, impairment Rs.4,962 Cr +2% YoY
- UltraTech/Regulatory↓[HIGH RISK]▼
CCI penalties Rs.1,804 Cr + Rs.68 Cr pending appeals, Rs.180 Cr deposited (10% of larger), emphasis of matter in audit
- Mahindra & Mahindra/Subsidiary Decline↓[MEDIUM RISK]▼
Carnot FY26 revenue Rs.19.8 Cr -14% YoY from Rs.23.08 Cr FY25/-20% from Rs.24.81 Cr FY24
- Sun Pharma/Deal Risks↓[MEDIUM RISK]▼
Organon acquisition close early 2027 subject to regulatory/stockholder approvals, funded by cash/bank debt to 2.3x Net Debt/EBITDA
- Infosys/Margin Headwinds↓[MEDIUM RISK]▼
FY26 margins 21% resilient but FY27 guide 20-22% amid 1% drag from third-party rev, 70 bps on-site mix
- LTTS/Discontinued Ops[LOW-MEDIUM RISK]▼
SWC business as discontinued, Q4 large deals 40% Mobility but segment flat QoQ
- State Bank of India/Governance↓[LOW RISK]▼
8 director nominees for May 15 AGM election, withdrawals possible by May 11
- Integra Switchgear/Pre-Earnings↓[LOW RISK]▼
Board meet May 4 for FY26 results, no metrics yet but watch for potential weakness
Opportunities(10)
- Sun Pharma/Organon Acquisition↓(OPPORTUNITY)◆
$11.75B deal creates top-25 global pharma with $12.4B rev, #7 biosimilars, 150-country presence; funded cash/debt
- Trent/Bonus + Dividend↓(OPPORTUNITY)◆
1:2 bonus RD May 29, dividend RD June 10/pay June 26 post-AGM June 23, undervalued capital return play
- UltraTech/Dividend Yield↓(OPPORTUNITY)◆
2400% payout Rs.240/share on strong FY26 results, India Cements sub since Dec 2024 boosts capacity
- LTTS/Lakshya 31-Plan(OPPORTUNITY)◆
13-15% CAGR target over 5 years, 16-17% EBIT margins from FY26 15.2% (EBIT +40 bps QoQ), $855M deals +40% YoY
- SBI Cards/FY Growth↓(OPPORTUNITY)◆
+10.1% YoY revenue, +13% PAT, assets +1.2% YoY to Rs.66,328 Cr; Q4 PAT +9.5% QoQ
- L&T Realty/Expansion(OPPORTUNITY)◆
Gurugram 3.6M sq ft + FY26 3M sq ft acquisitions, consolidating realty into single entity amid India RE boom
- TCS/Siemens MoU(OPPORTUNITY)◆
AI/factory modernization deals enhance IT leadership, supports AI infra growth vs Infosys modest guide
- Power Grid/Fundraise↓(OPPORTUNITY)◆
Apr 30 board for term loans/credit, infra capex tailwind in power transmission
- Kotak Mahindra/Earnings↓(OPPORTUNITY)◆
May 2 call for FY26 results, potential deposit/loan growth beats post-SBI Cards strength
- HDFC Bank/Governance↓(OPPORTUNITY)◆
98% director approval signals stability, no promoter votes but high institutional buy-in
Sector Themes(6)
- Pharma M&A Momentum◆
Sun Pharma's $11.75B Organon deal (top-3 Women's Health, doubles EBITDA) highlights consolidation; positive sentiment 10/10 materiality vs neutral filings [BULLISH IMPLICATION: Scale drives outperformance]
- IT/Services Modest Growth◆
Infosys FY26 +3.1% CC/FY27 1.5-3.5% guide, LTTS +8.3% but Q4 -1.7% QoQ, TCS MoUs positive; 3/5 mixed sentiment from AI/client headwinds, margins resilient 20-22% [CAUTION: Watch productivity drags]
- Financials Steady Expansion◆
SBI Cards FY26 rev +10.1%/PAT +13% but Q4 -3.7% QoQ; Kotak/HDFC calls/governance neutral-positive; avg YoY growth ~10% outperforms IT [BULLISH: Loan/asset trends]
- Capital Returns Surge◆
Trent 1:2 bonus + dividend, UltraTech 2400% payout; 3/20 filings show aggressive returns vs reinvestment in infra/pharma [ATTRACTIVE: Yield hunters]
- Cement/Infra Mixed◆
UltraTech high dividend but Rs.1,804 Cr penalties, Power Grid fundraising, L&T land grabs; operational expansions offset reg risks [NEUTRAL: Catalyst-driven]
- Retail/Consumer Stability◆
Trent bonus/AGM, M&M Carnot stake-up despite -14% sub rev; neutral actions signal confidence amid macro caution [STABLE: Event plays]
Watch List(8)
Apr 30 fundraise proposal via term loans/credit; gauge size/terms for capex visibility [Apr 30, 2026]
- LTTS/Investor Meets👁
Post-FY26 mixed results (Q4 -1.7% QoQ), monitor Lakshya execution vs 13-15% CAGR target
Bonus RD May 29, dividend RD June 10, AGM June 23; approval risks via postal ballot [May-Jun 2026]
FY26 results discussion May 2 at 5:30 PM IST; compare to SBI Cards +10% YoY [May 2, 2026]
Director elections May 15, nominations withdrawable by May 11; board refresh impact [May 15, 2026]
Organon acquisition recording available; watch regulatory updates for early 2027 close
Dividend approval + CCI appeals (Rs.1,804 Cr); unmodified audit but emphasis matter [Upcoming AGM]
FY26 results approval May 4; potential outlier in small-cap results vs Sensex peers [May 4, 2026]
Filing Analyses(20)
27-04-2026
Sun Pharmaceutical Industries Limited has entered a definitive agreement to acquire all outstanding shares of Organon & Co. for US$14.00 per share in cash, at an enterprise value of US$11.75 billion. The deal positions the combined entity among the top 25 global pharmaceutical companies with pro forma revenue of US$12.4 billion, a top-3 player in Women's Health, 7th largest in biosimilars, and nearly doubles EBITDA and cash flow, though from a post-transaction Net Debt/EBITDA of 2.3x. The transaction, approved by both boards, is expected to close in early 2027 subject to regulatory approvals and Organon stockholder approval.
- ·Organon portfolio includes more than 70 products commercialized across 140 countries.
- ·Combined presence in 150 countries with 18 large markets each generating over US$100 million revenues.
- ·Transaction to be funded by cash resources and bank financing; effected via merger with Sun Pharma subsidiary.
- ·Advisors: J.P. Morgan Securities LLC and Jefferies LLC (Sun Pharma financial); Morgan Stanley & Co. LLC and Goldman Sachs (Organon financial).
27-04-2026
Power Grid Corporation of India Limited (POWERGRID) has intimated the stock exchanges that a Board of Directors meeting is scheduled for Thursday, April 30, 2026, to consider a proposal for fund raising through Unsecured Rupee Term Loan / Line of Credit (Bank Facility). This disclosure complies with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. No financial details or outcomes were provided in the intimation.
- ·NSE Scrip ID: POWERGRID; BSE Scrip Code: 532898; EQ – ISIN: INE752E01010
- ·CIN: L40101DL1989GOI038121
- ·Corporate Office: “Saudamini”, Plot No. 2, Sector-29, Gurugram-122001, (Haryana)
- ·Registered Office: B-9, Qutab Institutional Area, Katwaria Sarai, New Delhi-110 016
27-04-2026
LTTS reported FY26 revenue from continued operations of $1,233 Mn, up 8.3% YoY, with Tech segment (including Intelliswift) growing 19.7%, Sustainability 12.8%, and large deal wins reaching $855 Mn (+40% YoY); North America grew 12% while other geos showed positive growth. However, Q4 FY26 revenue was $306 Mn, up only 0.3% YoY but down 1.7% QoQ due to strategic portfolio rationalization, with Mobility segment remaining flat sequentially despite over 40% of Q4 large deals in the segment. The company launched its Lakshya 31-Plan targeting 13-15% CAGR over the next 5 years and EBIT margins of 16-17%, alongside leadership promotions and EBIT margins expanding 40 bps QoQ to 15.2%.
- ·SWC business classified as discontinued operations.
- ·Over 40% of Q4 large deals in Mobility; over 50% in Sustainability.
- ·Strategic partnership with global energy major for 500+ engineers in digital expertise.
- ·Leadership reorganization: Alind Saxena to drive strategic initiatives and large deals; promotions for Subrat Tripathy and Srinath Nagarur.
- ·Past 5-year CAGR: 12.4% vs. industry 8%.
27-04-2026
Trent Limited announced Friday, 29th May 2026 as the Record Date for issuance of bonus equity shares in the proportion of 1:2 (one bonus share for every two existing fully paid equity shares). The issuance is subject to statutory and regulatory approvals as well as shareholder approval via Postal Ballot. The intimation has been made available on the company's website www.trentlimited.com.
- ·Stock Symbol: TRENT (NSE), Scrip Code: 500251 (BSE)
- ·Membership No.: 16536
27-04-2026
SBI Cards and Payment Services Limited disclosed the audio recording of their Q4 FY26 Earnings Call held on April 27, 2026, with analysts/investors, in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015. The recording is available at the provided link on the company's website.
- ·Date & Time of event: April 27, 2026 at around 04:30 PM
- ·Audio recording link: https://www.sbicard.com/en/who-we-are/analyst-investor-meeting.page
- ·Scrip Code: 543066, Symbol: SBICARD, Security: Equity Shares/Debentures
27-04-2026
Mahindra & Mahindra Ltd has acquired an additional 28.03% stake in its subsidiary Carnot Technologies Private Limited for Rs. 6.72 crore, increasing its equity holding to 80.72% and voting rights to 89%, aligning with its strategy in precision farming and telematics. Carnot reported FY26 revenue of Rs. 19.80 crore, marking a decline from Rs. 23.08 crore in FY25 and Rs. 24.81 crore in FY24, alongside PAT of Rs. 1.17 crore and net worth of Rs. 6.00 crore. The transaction is a related party deal on arm's length basis, with completion expected in May 2026.
- ·Share purchase price: Rs.11,978 per share
- ·Carnot date of incorporation: 24th August 2015
- ·Transaction executed on April 27, 2026 at 06:11 p.m., indicative completion: May 2026
- ·No governmental or regulatory approvals required
27-04-2026
Sun Pharmaceutical Industries Limited announced the availability of an audio recording of an investor call held on April 27, 2026, pertaining to the acquisition of Organon & Co. The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the recording is accessible on the company's website via a provided link. No financial metrics, performance data, or further details on the acquisition are included in this filing.
- ·Filing reference to Scrip Symbol: SUNPHARMA and Scrip Code: 524715
- ·CIN: L24230GJ1993PLC019050
- ·Audio link: https://sunpharma.com/wp-content/uploads/2026/04/FY26-27April-2026-Investor-Call-Recording- Acquisition-of-Organon-Co.mp3
27-04-2026
Kotak Mahindra Bank Limited has informed stock exchanges about an upcoming Earnings Conference Call on Saturday, May 02, 2026, at 5:30 p.m. IST to discuss the Consolidated and Standalone Audited Financial Results for the quarter and financial year ended March 31, 2026. The Investor Presentation, audio recording, and transcript will be available on the Bank's website post-call. Dial-in details include +91 22 6280 1215 / +91 22 7115 8116 with pre-registration via Diamond Pass.
- ·BSE Scrip codes: 500247, 958687, 974396
- ·NSE Symbols: KOTAKBANK, KMBL (Codes: 974682, 974924, 975387); KMB26, KMB29, KMB30
- ·Website for materials: https://www.kotak.bank.in/en/investor-relations/financial-results.html
- ·Disclosure website: https://www.kotak.bank.in/en/investor-relations/governance/sebi-listing-disclosures.html
- ·Pursuant to Regulation 30 and 46 of SEBI (LODR) Regulations, 2015
27-04-2026
State Bank of India has published the list of 8 validly nominated candidates for the election of 4 Directors to its Central Board under Section 19(c) of the State Bank of India Act, 1955, at the General Meeting of Shareholders on May 15, 2026, at 3:00 PM via Video Conferencing/Other Audio Visual Means. The notice follows the original announcement dated March 18, 2026, published in the Gazette of India on March 23, 2026. Candidates may withdraw nominations by delivering a physical request to the Managing Director by May 11, 2026, 5:00 PM.
- ·Meeting venue: State Bank Auditorium, State Bank Bhavan, Madame Cama Road, Mumbai – 400021 (Maharashtra)
- ·Withdrawal requests to be delivered to: Managing Director (Corporate Banking & Subsidiaries), State Bank Bhavan, Madame Cama Road, Nariman Point, Mumbai-400021
- ·Original notice dated March 18, 2026; Gazette publication March 23, 2026; newspaper publication March 24, 2026
27-04-2026
UltraTech Cement Limited informed stock exchanges that the audio recording of the earnings call held on April 27, 2026, discussing financial results for the quarter and year ended March 31, 2026, is now available at https://www.ultratechcement.com/investors/financials. This disclosure complies with Regulation 30 of SEBI (LODR) Regulations, 2015, following a prior intimation letter dated April 9, 2026. No specific financial metrics or performance details were provided in the filing.
- ·Scrip Codes: BSE 532538, NSE ULTRACEMCO, Luxembourg US90403E1038 and US90403E2028, Singapore ISIN US90403YAA73 and US90403BAA18
- ·Registered Office: Ahura Centre, B-Wing, 2nd Floor, Mahakali Caves Road, Andheri (East), Mumbai 400 093, India
- ·CIN: L26940MH2000PLC128420
27-04-2026
Adani Ports and Special Economic Zone Limited published a newspaper advertisement on April 27, 2026, in Business Standard (Ahmedabad and Mumbai editions) notifying shareholders of the IEPFA's Second 100 Days Campaign 'Saksham Niveshak' from April 1, 2026, to July 9, 2026. The campaign encourages updating KYC, nomination details, bank mandates, and claiming unpaid/unclaimed dividends to prevent transfer of shares and dividends to the Investor Education and Protection Fund (IEPF). Shareholders are advised to contact the Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, or use the SWAYAM portal for assistance.
- ·RTA address: C-101, Embassy 247, L B.S. Marg, Vikhroli (West), Mumbai - 400083
- ·RTA phone: 8108116767
- ·Company website: www.adaniports.com
- ·Scrip codes: 532921 (BSE), ADANIPORTS (NSE)
27-04-2026
Infosys delivered FY26 revenue growth of 3.1% in constant currency terms, with Q4 growth at 4.1% YoY CC, supported by strong performance in Financial Services, Communications, Manufacturing, and Europe, alongside large deals of $14.9B for the year (28% YoY increase) and $3.2B in Q4. AI services revenue grew beyond 5.5% of total revenue in Q4 from Q3 levels. However, FY27 revenue guidance is modest at 1.5% to 3.5% YoY CC amid competitive intensity, AI productivity impacts, and client spending compression, with operating margins guided at 20% to 22%; FY26 margins were resilient at 21% despite headwinds like 1% drag from lower third-party revenue and 70 bps from on-site mix.
- ·Employee count declined by over 8,000 in the last five to six quarters.
- ·Stratus acquisition closed and contributes 25 basis points to FY27 guidance; Optimum and Australian JV pending regulatory approvals, not yet included.
- ·Q4 margin headwinds: 50 bps from acquisition amortization, 20 bps from comp, partially offset by 40 bps currency benefit and 30 bps from Maximus.
- ·AI total addressable market estimated at $300-400B by 2030.
- ·Net new large deals at 55% for FY26.
27-04-2026
Trent Limited has scheduled its Seventy-Fourth Annual General Meeting (AGM) for Tuesday, June 23, 2026. The Board of Directors has fixed the Record Date for dividend payment as Wednesday, June 10, 2026, subject to shareholder approval at the AGM. Dividend, if approved, will be paid on or after Friday, June 26, 2026, to beneficial owners and physical shareholders as per specified procedures.
- ·Stock symbol: TRENT (NSE), Scrip Code: 500251 (BSE)
- ·Intimation available on company website: www.trentlimited.com
- ·Company Secretary Membership No.: 16536
27-04-2026
L&T Realty Properties Ltd (LTRPL), a wholly-owned subsidiary of Larsen & Toubro Limited, acquired 100% stake in International Green Scapes Ltd (IGSL), securing 20 acres of land in Gurugram with a development potential of 3.6 million square feet, marking its first acquisition in the NCR region. During FY 2025-26, LTRPL and L&T Realty Developers Ltd cumulatively acquired lands across Mumbai, Delhi, and Bengaluru with an aggregate development potential of 3 million square feet. L&T is consolidating its realty businesses into a single entity to capitalize on India's real estate growth.
- ·Acquisition enables leveraging IGSL's land for urban-premium and luxury real estate segments.
- ·L&T operates in EPC Projects, Hi-Tech Manufacturing, and Services across multiple geographies.
27-04-2026
Tata Consultancy Services (TCS) has signed two Memorandums of Understanding (MoUs) with Siemens Energy AG and Siemens Energy India Limited to enhance collaboration in IT services, AI-led industrial transformation, factory modernization, and AI infrastructure. The partnership combines TCS's AI, data, and engineering strengths with Siemens Energy's expertise in power generation and grid technologies, including Siemens Energy India supporting TCS's HyperVault AI data center business to meet energy demands. This builds on a two-decade partnership to drive innovation, operational resilience, and sustainable growth.
- ·Siemens Energy AG has a legacy of over 150 years.
- ·TCS founded in 1968, aspires to be the world's largest AI-led technology services company.
- ·Partnership focuses on IT services, AI and factory modernization, and AI infrastructure development in India.
27-04-2026
The Board of UltraTech Cement Limited approved the Standalone and Consolidated Annual Audited Financial Results for the year ended 31st March, 2026, with an unmodified audit opinion, and recommended a dividend of 2400% (Rs. 240 per equity share of Rs. 10 each) subject to AGM approval. However, the auditor's report emphasizes ongoing CCI penalty matters totaling Rs. 1,804.31 crores and Rs. 68.30 crores, against which Rs. 180.43 crores has been deposited as an asset with no provision recognized based on legal opinion.
- ·Financial results cover the Group including multiple wholly-owned subsidiaries, associates, and joint ventures such as Star Cement Co. L.L.C. and PT Anggana Energy Resources.
- ·Board meeting held on 27th April, 2026, from 12 noon to 2.20 p.m.
- ·The India Cements Limited included as subsidiary w.e.f. 24 December 2024.
27-04-2026
HDFC Bank announced the results of the postal ballot on April 27, 2026, for the special resolution to re-appoint Dr. (Mrs.) Sunita Maheshwari (DIN: 01641411) as an Independent Director, which passed with 98.322% votes in favor (9,837,911,683 votes) and 1.678% against (167,894,187 votes) out of 10,005,805,870 votes polled, representing 65.007% of 15,391,982,634 total outstanding shares. Public institutions had high turnout of 88.462% with 98.329% approval, while public non-institutions showed low turnout of 0.617% but 95.522% approval; no promoter votes were cast. The resolution is deemed approved as of the e-voting closure on April 26, 2026.
- ·No votes from Promoters and Promoter Group.
- ·No poll or postal ballot voting; all via e-voting.
- ·Postal Ballot Notice dated March 26, 2026; scrutinizer report dated April 27, 2026.
27-04-2026
SBI Cards and Payment Services Limited approved audited financial results for the quarter and FY ended March 31, 2026, with FY26 revenue from operations up 10.1% YoY to ₹19,899.63 Cr and PAT rising 13.0% YoY to ₹2,166.71 Cr on higher interest and fees income. However, Q4 FY26 revenue fell 3.7% QoQ to ₹4,934.50 Cr from ₹5,127.26 Cr despite 5.6% YoY growth, while total expenses appear lower QoQ supporting 9.5% QoQ PAT growth to ₹609.30 Cr. Balance sheet strengthened with total assets up 1.2% YoY to ₹66,327.79 Cr and loans growing 2.0% to ₹54,984.36 Cr.
- ·Audited by Joint Statutory Auditors M/s. V.K. Dhingra & Co. and M/s. S.P. Chopra & Co.
- ·Board meeting held on April 27, 2026, commenced at 12:30 PM and concluded at 02:33 PM.
- ·FY26 impairment on financial instruments ₹4,962.39 Cr, up slightly YoY from ₹4,871.51 Cr.
- ·Paid-up equity share capital ₹951.60 Cr (face value ₹10 each); Basic EPS FY26 ₹22.77.
27-04-2026
The Board of UltraTech Cement Limited approved the standalone and consolidated annual audited financial results for the year ended 31st March, 2026, and recommended a dividend of 2400% at the rate of Rs. 240 per equity share of Rs. 10 each, subject to AGM approval. Auditors issued reports with unmodified opinions confirming a true and fair view. However, an emphasis of matter notes pending appeals against CCI penalties of Rs. 1,804.31 crores and Rs. 68.30 crores, with Rs. 180.43 crores deposited equivalent to 10% of the larger penalty.
- ·Board meeting held on 27th April, 2026, commenced at 12 noon and concluded at 2.20 p.m.
- ·The India Cements Limited became subsidiary w.e.f. 24 December 2024
- ·Auditors' reports include unmodified opinion under Regulation 33 of Listing Regulations
27-04-2026
Integra Switchgear Ltd. (scrip code 517423) has intimated the Bombay Stock Exchange that a Board of Directors meeting will be held on Monday, May 4, 2026, at the company's registered office to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The notice was issued on April 27, 2026, by Company Secretary Rehanabibi Rijwan Kudalkar. No financial data or performance metrics are disclosed in this pre-meeting intimation.
- ·Scrip code: 517423
- ·Meeting agenda: Approve audited standalone and consolidated financial results for quarter/year ended 31st March, 2026
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 20 filings
More from: BSE Sensex 30 Stocks Regulatory Filings
🇮🇳 More from India
View all →April 20, 2026
India Pre-Market Regulatory Roundup — April 20, 2026
India Pre-Market Regulatory Roundup
April 20, 2026
India Quarterly Results BSE NSE Announcements — April 20, 2026
India Quarterly Results BSE NSE Announcements
April 20, 2026
India Upcoming Corporate Actions BSE NSE — April 20, 2026
India Upcoming Corporate Actions BSE NSE
April 20, 2026
BSE FMCG Sector Regulatory Filings — April 20, 2026
BSE FMCG Sector Regulatory Filings